James, H A and Gibson, Ian (1998) The therapeutic potential of ribozymes. Blood, 91 (2). pp. 371-82. ISSN 0006-4971
Full text not available from this repository. (Request a copy)Abstract
Ribozymes are catalytic RNA molecules that recognize their target RNA in a highly sequence-specific manner. They can therefore be used to inhibit deleterious gene expression (by cleavage of the target mRNA) or even repair mutant cellular RNAs. Targets such as the mRNAs of oncogenes (resulting from base mutations or chromosome translocations, eg, ras or bcr-abl) and viral genomes and transcripts (human immunodeficiency virus-type 1 [HIV-1]) are ideal targets for such sequence-specific agents. The aim of this review is therefore to introduce the different classes of ribozymes, highlighting some of the chemistry of the reactions they catalyze, to address the specific inhibition of genes by ribozymes, the problems yet to be resolved, and how new developments in the field give hope to the future for ribozymes in the therapeutic field.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | gene expression regulation,genetic therapy,humans,rna, catalytic,sdg 3 - good health and well-being ,/dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being |
Faculty \ School: | Faculty of Science > School of Biological Sciences |
Depositing User: | Pure Connector |
Date Deposited: | 27 Nov 2013 13:24 |
Last Modified: | 24 Oct 2022 05:12 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/45038 |
DOI: |
Actions (login required)
View Item |